India, Sept. 1 -- The Government of India issued the following news release:
A newly designed nitro-substituted organoselenium compound can reduce the invasiveness of aggressive triple-negative breast cancer cells by modulating various signalling pathways.
Nature has inspired many drug discovery strategies, including design and synthesis. Organoselenium compounds, some sourced from plants and others synthesised in the lab are gaining attention for their biological activities. However, their ability to target interconnected oncogenic signalling networks has not been extensively studied, prompting research into their structural modifications and anticancer properties.
Research jointly led by Dr. Asis Bala, at the Institute of Advanced Stud...